Name: UMIN ID:
Unique ID issued by UMIN | UMIN000032717 |
---|---|
Receipt number | R000026223 |
Scientific Title | Usefulness of Add-on Therapy of Pegylated Interferon alfa2a with Nucleoside/nucleotide Analog Treatment for Patients with Hepatitis B Virus Infection |
Date of disclosure of the study information | 2018/05/25 |
Last modified on | 2021/05/28 23:14:54 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2018/05/25 11:55:13 | ||
2 | Update | 2018/05/25 11:56:16 | Recruitment status |
|
3 | Update | 2018/11/27 10:34:53 | Publication of results |
|
4 | Update | 2021/05/28 23:11:59 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Tel1 Organization Organization Address Address Tel |
|
5 | Update | 2021/05/28 23:14:08 | Recruitment status Date of IRB Anticipated trial start date Last follow-up date |
|
6 | Update | 2021/05/28 23:14:54 | Number of participants that the trial has enrolled |